ID   E2AK1_HUMAN             Reviewed;         630 AA.
AC   Q9BQI3; A8K2R2; Q549K6; Q8NBW3; Q9HC02; Q9NYE0; Q9P0V6; Q9P1J5;
AC   Q9P2H8; Q9UHG4;
DT   11-JUL-2001, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2003, sequence version 2.
DT   15-MAR-2017, entry version 166.
DE   RecName: Full=Eukaryotic translation initiation factor 2-alpha kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Heme-controlled repressor;
DE            Short=HCR;
DE   AltName: Full=Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase;
DE   AltName: Full=Heme-regulated inhibitor;
DE   AltName: Full=Hemin-sensitive initiation factor 2-alpha kinase;
GN   Name=EIF2AK1; Synonyms=HRI, KIAA1369; ORFNames=PRO1362;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hair follicle dermal papilla;
RX   PubMed=11101152; DOI=10.1007/s100590000016;
RA   Hwang S.-Y., Kim M.-K., Kim J.-C.;
RT   "Cloning of hHRI, human heme-regulated eukaryotic initiation factor
RT   2alpha kinase: down-regulated in epithelial ovarian cancers.";
RL   Mol. Cells 10:584-591(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Tu Q., Yu L., Hu P.R., Fu Q., Cui Y.Y., Zhao S.Y.;
RT   "Cloning and sequencing of a novel human cDNA homologous to rat hemin-
RT   sensitive initiation factor 2a kinase mRNA.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RA   Cannon G., Naik S.M., Boss J.M., Caughman S.W.;
RT   "Cloning of the human heme-regulated eukaryotic initiation factor 2-
RT   alpha kinase from TNF-alpha stimulated dermal microvascular
RT   endothelial cells.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hypothalamus;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   PubMed=12391722; DOI=10.1080/10425170290023428;
RA   Omasa T., Chen Y.-G., Mantalaris A., Tsai Y.C., Wu J.H.;
RT   "Molecular cloning and sequencing of the human heme-regulated
RT   eukaryotic initiation factor 2 alpha (eIF-2 alpha) kinase from bone
RT   marrow culture.";
RL   DNA Seq. 13:133-137(2002).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-558.
RC   TISSUE=Placenta, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 450-630, AND VARIANT
RP   ARG-558.
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Wei H., Zhou G., Ouyang S., Luo L., Bi J.,
RA   Liu M., He F.;
RT   "Functional prediction of the coding sequences of 121 new genes
RT   deduced by analysis of cDNA clones from human fetal liver.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   INTERACTION WITH CDC37 AND THE HSP90 COMPLEX.
RX   PubMed=11036079; DOI=10.1074/jbc.M007583200;
RA   Shao J., Grammatikakis N., Scroggins B.T., Uma S., Huang W.,
RA   Chen J.-J., Hartson S.D., Matts R.L.;
RT   "Hsp90 regulates p50(cdc37) function during the biogenesis of the
RT   active conformation of the heme-regulated eIF2 alpha kinase.";
RL   J. Biol. Chem. 276:206-214(2001).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   TISSUE SPECIFICITY.
RX   PubMed=20071449; DOI=10.1124/mol.109.061259;
RA   Acharya P., Chen J.J., Correia M.A.;
RT   "Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor
RT   2alpha kinase: a protagonist of heme-mediated translational control of
RT   CYP2B enzymes and a modulator of basal endoplasmic reticulum stress
RT   tone.";
RL   Mol. Pharmacol. 77:575-592(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-117; THR-132; LYS-134; SER-139;
RP   HIS-145; SER-202; LEU-292; HIS-319 AND ARG-558.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Inhibits protein synthesis at the translation initiation
CC       level, in response to various stress conditions, including
CC       oxidative stress, heme deficiency, osmotic shock and heat shock.
CC       Exerts its function through the phosphorylation of EIF2S1 at 'Ser-
CC       48' and 'Ser-51', thus preventing its recycling. Binds hemin
CC       forming a 1:1 complex through a cysteine thiolate and histidine
CC       nitrogenous coordination. This binding occurs with moderate
CC       affinity, allowing it to sense the heme concentration within the
CC       cell. Thanks to this unique heme-sensing capacity, plays a crucial
CC       role to shut off protein synthesis during acute heme-deficient
CC       conditions. In red blood cells (RBCs), controls hemoglobin
CC       synthesis ensuring a coordinated regulation of the synthesis of
CC       its heme and globin moieties. Thus plays an essential protective
CC       role for RBC survival in anemias of iron deficiency. Similarly, in
CC       hepatocytes, involved in heme-mediated translational control of
CC       CYP2B and CYP3A and possibly other hepatic P450 cytochromes. May
CC       also contain ER stress during acute heme-deficient conditions (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Induced by acute heme depletion, that not only
CC       increases EIF2AK1 protein levels, but also stimulates kinase
CC       activity by autophosphorylation. Inhibited by the heme-degradation
CC       products biliverdin and bilirubin. Induced by oxidative stress
CC       generated by arsenite treatment. Binding of nitric oxide (NO) to
CC       the heme iron in the N-terminal heme-binding domain activates the
CC       kinase activity, while binding of carbon monoxide (CO) suppresses
CC       kinase activity (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Synthesized in an inactive form that binds to the N-
CC       terminal domain of CDC37. Has to be associated with a multiprotein
CC       complex containing Hsp90, CDC37 and PPP5C for maturation and
CC       activation by autophosphorylation. The phosphatase PPP5C modulates
CC       this activation. Forms oligomers. Has been reported as a non-
CC       covalently bound homodimer, as well as a hexamer in the absence of
CC       hemin. Converted to an inactive disulfide linked homodimer in the
CC       presence of hemin (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BQI3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BQI3-2; Sequence=VSP_007589;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in erythroid cells. At
CC       much lower levels, expressed in hepatocytes (at protein level).
CC       {ECO:0000269|PubMed:20071449}.
CC   -!- PTM: Activated by autophosphorylation; phosphorylated
CC       predominantly on serine and threonine residues, but also on
CC       tyrosine residues. Autophosphorylation at Thr-488 is required for
CC       kinase activation. The active autophosphorylated form apparently
CC       is largely refractory to cellular heme fluctuations (By
CC       similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Can bind 1 molecules of heme per polypeptide chain.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. GCN2 subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF70289.1; Type=Frameshift; Positions=24, 26, 33; Evidence={ECO:0000305};
CC       Sequence=AAF71057.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA92607.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF255050; AAF70289.1; ALT_FRAME; mRNA.
DR   EMBL; AF100784; AAP97223.1; -; mRNA.
DR   EMBL; AF181071; AAF18391.1; -; mRNA.
DR   EMBL; AB037790; BAA92607.1; ALT_INIT; mRNA.
DR   EMBL; AF183414; AAG09683.1; -; mRNA.
DR   EMBL; AL136563; CAB66498.1; -; mRNA.
DR   EMBL; AF147094; AAF66736.1; -; mRNA.
DR   EMBL; AK075192; BAC11461.1; -; mRNA.
DR   EMBL; AK290327; BAF83016.1; -; mRNA.
DR   EMBL; AL834494; CAD39152.1; -; mRNA.
DR   EMBL; CH236963; EAL23714.1; -; Genomic_DNA.
DR   EMBL; CH878731; EAW55049.1; -; Genomic_DNA.
DR   EMBL; BC006524; AAH06524.1; -; mRNA.
DR   EMBL; AF116634; AAF71057.1; ALT_INIT; mRNA.
DR   CCDS; CCDS5345.1; -. [Q9BQI3-1]
DR   RefSeq; NP_001127807.1; NM_001134335.1. [Q9BQI3-2]
DR   RefSeq; NP_055228.2; NM_014413.3. [Q9BQI3-1]
DR   UniGene; Hs.520205; -.
DR   ProteinModelPortal; Q9BQI3; -.
DR   BioGrid; 118002; 7.
DR   IntAct; Q9BQI3; 4.
DR   MINT; MINT-4715350; -.
DR   STRING; 9606.ENSP00000199389; -.
DR   BindingDB; Q9BQI3; -.
DR   ChEMBL; CHEMBL6029; -.
DR   GuidetoPHARMACOLOGY; 2015; -.
DR   iPTMnet; Q9BQI3; -.
DR   PhosphoSitePlus; Q9BQI3; -.
DR   BioMuta; EIF2AK1; -.
DR   DMDM; 32172458; -.
DR   EPD; Q9BQI3; -.
DR   MaxQB; Q9BQI3; -.
DR   PaxDb; Q9BQI3; -.
DR   PeptideAtlas; Q9BQI3; -.
DR   PRIDE; Q9BQI3; -.
DR   DNASU; 27102; -.
DR   Ensembl; ENST00000199389; ENSP00000199389; ENSG00000086232. [Q9BQI3-1]
DR   GeneID; 27102; -.
DR   KEGG; hsa:27102; -.
DR   UCSC; uc003spp.4; human. [Q9BQI3-1]
DR   CTD; 27102; -.
DR   DisGeNET; 27102; -.
DR   GeneCards; EIF2AK1; -.
DR   H-InvDB; HIX0003741; -.
DR   HGNC; HGNC:24921; EIF2AK1.
DR   HPA; CAB022082; -.
DR   HPA; HPA016496; -.
DR   HPA; HPA061675; -.
DR   neXtProt; NX_Q9BQI3; -.
DR   OpenTargets; ENSG00000086232; -.
DR   PharmGKB; PA134919097; -.
DR   eggNOG; ENOG410ISBT; Eukaryota.
DR   eggNOG; ENOG410YD23; LUCA.
DR   GeneTree; ENSGT00530000062984; -.
DR   HOVERGEN; HBG051429; -.
DR   InParanoid; Q9BQI3; -.
DR   KO; K16194; -.
DR   OMA; EGVCYIH; -.
DR   OrthoDB; EOG091G03OR; -.
DR   PhylomeDB; Q9BQI3; -.
DR   TreeFam; TF329383; -.
DR   SignaLink; Q9BQI3; -.
DR   SIGNOR; Q9BQI3; -.
DR   ChiTaRS; EIF2AK1; human.
DR   GeneWiki; EIF2AK1; -.
DR   GenomeRNAi; 27102; -.
DR   PRO; PR:Q9BQI3; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000086232; -.
DR   CleanEx; HS_EIF2AK1; -.
DR   ExpressionAtlas; Q9BQI3; baseline and differential.
DR   Genevisible; Q9BQI3; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004694; F:eukaryotic translation initiation factor 2alpha kinase activity; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0002526; P:acute inflammatory response; IEA:Ensembl.
DR   GO; GO:0055072; P:iron ion homeostasis; IEA:Ensembl.
DR   GO; GO:0030225; P:macrophage differentiation; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0046986; P:negative regulation of hemoglobin biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0045993; P:negative regulation of translational initiation by iron; NAS:UniProtKB.
DR   GO; GO:0006909; P:phagocytosis; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0046501; P:protoporphyrinogen IX metabolic process; IEA:Ensembl.
DR   GO; GO:0010999; P:regulation of eIF2 alpha phosphorylation by heme; IEA:Ensembl.
DR   GO; GO:0009605; P:response to external stimulus; IEP:UniProtKB.
DR   GO; GO:0006950; P:response to stress; IEP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Disulfide bond; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Protein synthesis inhibitor; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    630       Eukaryotic translation initiation factor
FT                                2-alpha kinase 1.
FT                                /FTId=PRO_0000085941.
FT   DOMAIN      167    583       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REPEAT      410    415       HRM 1.
FT   REPEAT      552    557       HRM 2.
FT   NP_BIND     173    181       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    442    442       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     196    196       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   SITE         80     80       Heme-binding. {ECO:0000250}.
FT   MOD_RES     285    285       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q63185}.
FT   MOD_RES     486    486       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     488    488       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     493    493       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9Z2R9}.
FT   VAR_SEQ     244    244       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:12391722,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_007589.
FT   VARIANT     117    117       R -> T (in dbSNP:rs34889754).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040466.
FT   VARIANT     132    132       K -> T (in dbSNP:rs34851195).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040467.
FT   VARIANT     134    134       R -> K (in dbSNP:rs55744865).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040468.
FT   VARIANT     139    139       P -> S (in dbSNP:rs55963745).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040469.
FT   VARIANT     145    145       R -> H (in dbSNP:rs55971369).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040470.
FT   VARIANT     202    202       G -> S (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040471.
FT   VARIANT     292    292       F -> L (in dbSNP:rs55982710).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040472.
FT   VARIANT     319    319       L -> H (in dbSNP:rs34909691).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040473.
FT   VARIANT     558    558       K -> R (in dbSNP:rs2640).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.13}.
FT                                /FTId=VAR_015732.
FT   CONFLICT      2      2       Q -> L (in Ref. 3; AAF18391).
FT                                {ECO:0000305}.
FT   CONFLICT      4      4       G -> D (in Ref. 8; BAF83016).
FT                                {ECO:0000305}.
FT   CONFLICT     24     32       PPAIDFPAE -> RRHRLSRR (in Ref. 1;
FT                                AAF70289). {ECO:0000305}.
FT   CONFLICT    137    137       Q -> R (in Ref. 1; AAF70289).
FT                                {ECO:0000305}.
FT   CONFLICT    149    149       I -> T (in Ref. 8; BAF83016).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       A -> V (in Ref. 3; AAF18391).
FT                                {ECO:0000305}.
FT   CONFLICT    206    206       T -> P (in Ref. 7; AAF66736).
FT                                {ECO:0000305}.
SQ   SEQUENCE   630 AA;  71106 MW;  D63021651806620B CRC64;
     MQGGNSGVRK REEEGDGAGA VAAPPAIDFP AEGPDPEYDE SDVPAEIQVL KEPLQQPTFP
     FAVANQLLLV SLLEHLSHVH EPNPLRSRQV FKLLCQTFIK MGLLSSFTCS DEFSSLRLHH
     NRAITHLMRS AKERVRQDPC EDISRIQKIR SREVALEAQT SRYLNEFEEL AILGKGGYGR
     VYKVRNKLDG QYYAIKKILI KGATKTVCMK VLREVKVLAG LQHPNIVGYH TAWIEHVHVI
     QPRADRAAIE LPSLEVLSDQ EEDREQCGVK NDESSSSSII FAEPTPEKEK RFGESDTENQ
     NNKSVKYTTN LVIRESGELE STLELQENGL AGLSASSIVE QQLPLRRNSH LEESFTSTEE
     SSEENVNFLG QTEAQYHLML HIQMQLCELS LWDWIVERNK RGREYVDESA CPYVMANVAT
     KIFQELVEGV FYIHNMGIVH RDLKPRNIFL HGPDQQVKIG DFGLACTDIL QKNTDWTNRN
     GKRTPTHTSR VGTCLYASPE QLEGSEYDAK SDMYSLGVVL LELFQPFGTE MERAEVLTGL
     RTGQLPESLR KRCPVQAKYI QHLTRRNSSQ RPSAIQLLQS ELFQNSGNVN LTLQMKIIEQ
     EKEIAELKKQ LNLLSQDKGV RDDGKDGGVG
//
